Animal evidence considered in determination of cannabis smoke and <scp> Δ <sup>9</sup> </scp> ‐tetrahydrocannabinol as causing reproductive toxicity (developmental endpoint): Part <scp>III</scp> . Proposed neurodevelopmental mechanisms of action-Reference-Cited by-同舟云学术

Animal evidence considered in determination of cannabis smoke and Δ ⁹ ‐tetrahydrocannabinol as causing reproductive toxicity (developmental endpoint): Part III . Proposed neurodevelopmental mechanisms of action

Published:2022-09-20 Issue:18 Volume:114 Page:1169-1185
ISSN:2472-1727
Container-title:Birth Defects Research
language:en
Short-container-title:Birth Defects Research

Author:

Niknam Yassaman¹^ORCID,Iyer Poorni¹^ORCID,Campbell Marlissa A.¹,Moran Francisco¹^ORCID,Sandy Martha S.¹^ORCID,Zeise Lauren¹

Affiliation:

1. Office of Environmental Health Hazard Assessment (OEHHA)/Reproductive and Cancer Hazard Assessment Branch (RCHAB) California Environmental Protection Agency Sacramento California USA

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Developmental Biology,Toxicology,Embryology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdr2.2088

Reference76 articles.

1. Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (∆9-tetrahydrocannabinol) or CBD (cannabidiol) during gastrulation

2. At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring

3. Trajectories of brain development: point of vulnerability or window of opportunity?

4. A real time screening assay for cannabinoid CB1 receptor-mediated signaling

5. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (r)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Development of Cannabinoids as Therapeutic Agents in the United States;Pharmacological Reviews;2024-06-07